Published in J Biol Chem on August 12, 2013
Mechanism and function of oxidative reversal of DNA and RNA methylation. Annu Rev Biochem (2014) 1.36
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia (2013) 1.11
Playing TETris with DNA modifications. EMBO J (2014) 1.07
Hydroxymethylation as a Novel Environmental Biosensor. Curr Environ Health Rep (2014) 0.92
Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis (2015) 0.86
Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer. Gastric Cancer (2014) 0.86
Effects of particulate matter exposure on blood 5-hydroxymethylation: results from the Beijing truck driver air pollution study. Epigenetics (2015) 0.84
Mechanisms of superoxide signaling in epigenetic processes: relation to aging and cancer. Aging Dis (2015) 0.82
Genome-wide hydroxymethylcytosine pattern changes in response to oxidative stress. Sci Rep (2015) 0.82
Male obesity and subfertility, is it really about increased adiposity? Asian J Androl (2015) 0.76
Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease. J Neurochem (2016) 0.75
Dioxin induces Ahr-dependent robust DNA demethylation of the Cyp1a1 promoter via Tdg in the mouse liver. Sci Rep (2016) 0.75
TET1 exerts its tumor suppressor function by regulating autophagy in glioma cells. Biosci Rep (2017) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science (2009) 32.97
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet (2003) 25.57
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature (2010) 18.63
Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell (2011) 9.16
14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell (1997) 7.20
Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl (1987) 6.47
Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res (2007) 4.89
5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene (2002) 4.81
Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci (2011) 3.27
L1 retrotransposition in neurons is modulated by MeCP2. Nature (2010) 3.25
Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell (2011) 3.07
The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol (2003) 3.00
Studies in detoxication. XLIX. The metabolism of benzene containing (14C1) benzene. Biochem J (1953) 2.71
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A (2000) 2.70
Cancer epigenetics: linking basic biology to clinical medicine. Cell Res (2011) 1.88
Procainamide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem (2005) 1.84
Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis (2005) 1.60
Influence of oxygen radical injury on DNA methylation. Mutat Res (1997) 1.43
Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res (1993) 1.32
An overview of benzene metabolism. Environ Health Perspect (1996) 1.32
Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1. PLoS One (2013) 1.26
Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One (2012) 1.23
An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology (2012) 1.19
The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters. Blood (2012) 1.12
The role of epigenetic inactivation of 14-3-3sigma in human cancer. Cell Res (2005) 1.11
Oxidation reactions of cytosine DNA components by hydroxyl radical and one-electron oxidants in aerated aqueous solutions. Acc Chem Res (2010) 1.04
Alterations of DNA methylation by glutathione depletion. Cancer Lett (1997) 1.03
Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J Periodontol (2011) 1.01
Methylation-independent DNA binding modulates specificity of Repressor of Silencing 1 (ROS1) and facilitates demethylation in long substrates. J Biol Chem (2010) 0.99
5-Methylcytosine attack by hydroxyl free radicals and during carbon tetrachloride promoted liver microsomal lipid peroxidation: structure of reaction products. Chem Biol Interact (1996) 0.93
A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide. Leukemia (2010) 0.93
Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. J Cell Biochem (2009) 0.90
Elevated levels of benzene-related compounds in the urine of cigarette smokers. Int J Cancer (1994) 0.89
Early effects of hydroquinone on mitosis. Nature (1948) 0.89
The role of thiol reduction in hydroquinone-induced apoptosis in HEK293 cells. Chem Biol Interact (2003) 0.82
Induction of a trophoblast-like phenotype by hydralazine in the p19 embryonic carcinoma cell line. Biochim Biophys Acta (2012) 0.77
ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging. Cancer Res (2007) 1.45
Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells. Am J Physiol Cell Physiol (2002) 1.15
Uptake of lead and iron by divalent metal transporter 1 in yeast and mammalian cells. Biochem Biophys Res Commun (2002) 0.92
Protein kinase C activity and the relations between blood lead and neurobehavioral function in lead workers. Environ Health Perspect (2002) 0.86
MeCP2 deficiency enhances glutamate release through NF-κB signaling in myeloid derived cells. J Neuroimmunol (2013) 0.82
In vitro models to study the blood brain barrier. Methods Mol Biol (2011) 0.80
Blood-brain barrier and cell-cell interactions: methods for establishing in vitro models of the blood-brain barrier and transport measurements. Methods Mol Biol (2006) 0.80
Evaluation of the interactions between multiwalled carbon nanotubes and Caco-2 cells. J Toxicol Environ Health A (2012) 0.79
Identification of myristoylated alanine-rich C kinase substrate (MARCKS) in astrocytes. Front Biosci (2005) 0.77
Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity. Toxicol Sci (2004) 0.77
Induction of a trophoblast-like phenotype by hydralazine in the p19 embryonic carcinoma cell line. Biochim Biophys Acta (2012) 0.77
Aluminum stimulates uptake of non-transferrin bound iron and transferrin bound iron in human glial cells. Toxicol Appl Pharmacol (2007) 0.75
Hairless expression attenuates apoptosis in a mouse model and the COS cell line; involvement of p53. PLoS One (2010) 0.75